Julia Cheek, Everlywell, & its response to COVID-19

I interviewed Julia Cheek, CEO of Everlywell about their response to COVID-19. Last week they issued a $1m challenge to labs to promote the rapid capability to develop COVID-19 testing. Her goal is to get the US up to 250K home tests per day within a month, but it won’t be easy. This is the first in a series of news and tracking that THCB & Catalyst @ Health 2.0 will be doing on health tech companies’ response to the pandemic — Matthew Holt

The post Julia Cheek, Everlywell, & its response to COVID-19 appeared first on The Health Care Blog.

from The Health Care Blog https://ift.tt/2TTfkSp